Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |